Chimerix Inc (CMRX)
3.49
-0.17
(-4.64%)
USD |
NASDAQ |
Jan 08, 16:00
3.49
0.00 (0.00%)
After-Hours: 20:00
Chimerix SG&A Expense (Quarterly): 5.173M for Sept. 30, 2024
SG&A Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense Definition
SG&A expense (short for Selling, General and Administrative expense) is a line item on the income statement, though sometimes sales and marketing expenses are reported separately from general and administrative expenses.
SG&A Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (Quarterly) Benchmarks
| Cumberland Pharmaceuticals Inc | 7.073M |
| Abbott Laboratories | 2.895B |
| Emergent BioSolutions Inc | 76.60M |
| Tonix Pharmaceuticals Holding Corp | 7.707M |
| Geovax Labs Inc | 1.241M |